Deerfield Management’s ResMed RMD Stock Holding History

Deerfield Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,104	Closed	-$2.43M	–	139
2025 Q4	$2.43M	Buy	+10,104	New	+$2.58M	0.03%	87
2024 Q4	–	Sell	-2,933	Closed	-$716K	–	366
2024 Q3	$716K	Sell	2,933 -4,643	-61%	-$1.04M	0.01%	220
2024 Q2	$1.45M	Buy	+7,576	New	+$1.54M	0.02%	91
2024 Q1	–	Sell	-1,439	Closed	-$248K	–	423
2023 Q4	$248K	Buy	+1,439	New	+$221K	﹤0.01%	151
2015 Q1	–	Sell	-296,300	Closed	-$16.6M	–	129
2014 Q4	$16.6M	Buy	+296,300	New	+$15.5M	0.6%	46

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deerfield Management's RMD Position: Q1 2026 in Review

Deerfield Management sold out of ResMed (RMD) in Q1 2026, closing a stake of 10,104 shares — an estimated $2.43M sold.

Deerfield Management first reported a position in RMD in Q4 2014 and held it in 5 quarters. The position peaked at $16.6M in Q4 2014. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Deerfield Management reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Deerfield Management sold 10,104 ResMed shares in Q1 2026, an estimated $2.43M.
Deerfield Management first reported a position in ResMed in Q4 2014 and held it in 5 quarters.
Deerfield Management's ResMed position peaked at $16.6M in Q4 2014.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.